Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07218939 · ClinicalTrials.gov registry record

Universal Biospecimen Collection Protocol for Extra Material From Clinical Pulmonary Procedures

A clinical trial of Pulmonary, sponsored by M.D. Anderson Cancer Center.

Recruiting
Registry status
12,000
Enrollment target
1
Study location

NCT07218939: Recruiting study of Pulmonary, sponsored by M.D. Anderson Cancer Center.

NCT07218939 is a study of Pulmonary that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 12,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07218939, a study of Pulmonary, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.

RECRUITING
Registry status
12,000 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to develop a biospecimen collection protocol for unused biospecimens from pulmonary procedures in order to facilitate research across many different areas of pulmonary medicine and mitigate the pulmonary morbidity experienced by patients with cancer.

Primary Outcome

Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0

Conditions Studied

Study Locations (1)

Texas

  • The University of Texas M. D. Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 12,000 participants
Start Date 2025-10-08
Est. Completion 2032-12-01
M.D. Anderson Cancer Center

2,692 total trials

What NCT07218939 shows while recruiting

NCT07218939 is an observational study that tracks outcomes without assigning an intervention. Its 12,000 participants enrollment target places it among the larger protocols in the corpus.

The record links to 1 condition, with Pulmonary appearing as the primary indexed condition, and to 0 interventions.

NCT07218939 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT07218939 about?

NCT07218939 is a clinical study titled "Universal Biospecimen Collection Protocol for Extra Material From Clinical Pulmonary Procedures". The goal of this study is to develop a biospecimen collection protocol for unused biospecimens from pulmonary procedures in order to facilitate research across many different areas of pulmonary medicine and mitigate the pulmonary morbidity experienced by patients with cancer.

What is the current status of trial NCT07218939?

This trial is currently recruiting. The enrollment target is 12,000 participants. The study started on 2025-10-08. Estimated completion is 2032-12-01.

What conditions does trial NCT07218939 study?

This clinical trial studies the following conditions: Pulmonary.

Who is sponsoring clinical trial NCT07218939?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07218939 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01772771 · 12,000 participants

    Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program

  • NCT04937868 · 12,000 participants

    Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients

  • NCT06059963 · 12,000 participants

    A Prospective, Multi-center, Observational Study for Signal-C Test Evaluation

  • NCT06273618 · 12,000 participants · NA

    iLookOut Micro-learning to Improve Knowledge Retention

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07218939, the US trial registry maintained by the National Library of Medicine. NCT07218939 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.